
Sequences of primer sets used_
Gene targeted | Sequence | Size of amplified product (bp) | Ref |
---|---|---|---|
glmM | F: 5′-AAGCTTTTAGGGGTGTTAGGGGTTT-3′ | 294 | Santos et al. 2012 |
cagA | F: 5′-GATAACAGGCAAGCTTTTGAGG-3′ | 349 | Amin et al. 2019 |
sodB | F: 5′-GCCCTGTGGCGTTTGATTTCC-3′ | 425 | Ryberg et al. 2008 |
hsp60 | F: 5′-GCTCCAAGCATCACCAAAGACG-3′ | 603 | Ryberg et al. 2008 |
vacA | F: 5′-CAATCGTGTGGGTTCTGGAGC-3′ | 678 | Ryberg et al. 2008 |
vacAs1/s2 | F: 5′-ATGGAAATACAACAAACACAC-3′ | 259 | Harrison et al. 2017 |
vacAm1 | F: 5′-GGTCAAAATGCGGTCATGG-3′ | 290 | Harrison et al. 2017 |
vacAm2 | F: 5′-CATAACTAGCGCCTTGCAC-3′ | 352 | Harrison et al. 2017 |
TLR9-1486T/C, rs187084 | 5′-TTCATTCATTCAGCCTTCACTCA-3′ | 490 | Roszak et al. 2012 |
Distribution of H_ pylori among gastric tissue samples in studied gastric cancer patients_
Number | % | p-value | |
---|---|---|---|
Positive | 106 | 80.3 | 0.000* |
Negative | 26 | 19.7 | |
Total | 132 | 100% |
Distribution of genotypes of TLR9 -1486T/C, rs187084 polymorphism in studied groups_
Genotype frequency | Healthy study participants N = 106 | Gastric cancer patients N = 106 | OR | 95% CI | X2 | p-value | ||
---|---|---|---|---|---|---|---|---|
N | % | N | % | |||||
TT | 40 | 37.7 | 22 | 20.8 | 1.18 | 0.45–3.1 | 0.12 | 0.73 |
TC | 42 | 39.6 | 28 | 26.4 | 1.2 | 0.49–2.88 | 0.16 | 0.68 |
CC | 24 | 22.6 | 56 | 52.8 | 2.68 | 1.0–7.14 | 4.03 | 0.045* |
Demographic and histopathological data of the subjects included in the study_
Variable | Gastric cancer patients | Healthy study participants | p-value |
---|---|---|---|
Age | |||
Years (mean ± SD) | 56.55 ± 8.63 | 53.27 ± 8.55 | 0.93 |
Sex | |||
Male | 63 (59.4) | 59 (55.7%) | 0.76 |
Female | 43 (40.6%) | 47 (44.3%) | |
Differentiation of the tumor | |||
Well differentiated tumor | 16 (15.1%) | NA | – |
Moderately differentiated tumor | 35 (33.0%) | ||
Poorly differentiated tumor | 55 (51.9%) |
Distribution of virulence genes in H_ pylori strains isolated from gastric cancer patients_
Virulence gene | N = 106 | % | p-value |
---|---|---|---|
cagA | |||
Positive | 96 | 90.6 | 0.000* |
Negative | 10 | 9.4 | |
sodB | |||
Positive | 75 | 70.8 | 0.000* |
Negative | 31 | 29.2 | |
hsp60 | |||
Positive | 88 | 83.0 | 0.000* |
Negative | 18 | 17.0 | |
vacA | |||
Positive | 101 | 95.3 | 0.000* |
Negative | 5 | 4.7 | |
vacAs1/s2 | |||
Positive | 101 | 95.3 | 0.000* |
Negative | 5 | 4.7 | |
vacAm1 | |||
Positive | 56 | 52.8 | 0.56 |
Negative | 50 | 47.2 | |
vacAm2 | |||
Positive | 45 | 42.5 | 0.12 |
Negative | 61 | 57.5 |
The relation between virulence genes of H_ pylori and TLR9 -1486T/C, rs187084 genotypes in gastric cancer patients_
TLR9-1486T/C, rs187084 genotype | CC N = 56 | TT + TC N = 50 | p-value | ||
---|---|---|---|---|---|
Virulence gene | N | % | N | % | |
cagA | 55 | 98.2 | 41 | 82.0 | 0.075 |
sodB | 53 | 94.6 | 22 | 44.0 | 0.021* |
hsp60 | 53 | 94.6 | 35 | 70.0 | 0.049* |
vacA | 54 | 96.4 | 47 | 94.0 | 0.88 |
vacAs1/s2 | 54 | 96.4 | 47 | 94.0 | 0.88 |
vacAm1 | 35 | 62.5 | 21 | 42.0 | 0.048* |
vacAm2 | 19 | 33.9 | 26 | 52.0 | 0.81 |